Patents by Inventor Rakesh Kumar

Rakesh Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Integrated MEMS-CMOS devices and methods for fabricating MEMS devices and CMOS devices
    Patent number: 9546090
    Abstract: Integrated MEMS-CMOS devices and methods for fabricating MEMS devices and CMOS devices are provided. An exemplary method for fabricating a MEMS device and a CMOS device includes forming the CMOS device in and/or over a first side of a semiconductor substrate. Further, the method includes forming the MEMS device in and/or under a second side of the semiconductor substrate. The second side of the semiconductor substrate is opposite the first side of the semiconductor substrate.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: January 17, 2017
    Assignee: GLOBALFOUNDRIES SINGAPORE PTE. LTD.
    Inventors: Jia Jie Xia, Nagarajan Ranganathan, Rakesh Kumar, Aveek Nath Chatterjee
  • COMBINATION THERAPEUTIC NANOPARTICLES
    Publication number: 20170000740
    Abstract: Nanoparticles that include a chemotherapeutic agent and an anti-inflammatory are particularly cytotoxic to prostate cancer cells.
    Type: Application
    Filed: April 9, 2014
    Publication date: January 5, 2017
    Inventors: Shanta Dhar, Rakesh Kumar Pathak
  • Combination
    Publication number: 20160375086
    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering a proteasome inhibiting compound, and N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, and optional additional antineoplastic agents, to a human in need thereof.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Inventor: Rakesh Kumar
  • REAL-TIME HUMAN-MACHINE COLLABORATION USING BIG DATA DRIVEN AUGMENTED REALITY TECHNOLOGIES
    Publication number: 20160378861
    Abstract: A computing system includes a vision-based user interface platform to, among other things, analyze multi-modal user interactions, semantically correlate stored knowledge with visual features of a scene depicted in a video, determine relationships between different features of the scene, and selectively display virtual elements on the video depiction of the scene. The analysis of user interactions can be used to filter the information retrieval and correlating of the visual features with the stored knowledge.
    Type: Application
    Filed: October 8, 2015
    Publication date: December 29, 2016
    Inventors: Jayakrishnan Eledath, Supun Samarasekera, Harpreet S. Sawhney, Rakesh Kumar, Mayank Bansal, Girish Acharya, Michael John Wolverton, Aaron Spaulding, Ron Krakower
  • METHOD AND APPARATUS FOR ROUTING TRAFFIC USING ASYMMETRICAL OPTICAL CONNECTIONS
    Publication number: 20160344506
    Abstract: A method, computer-readable storage device and apparatus for routing traffic in a reconfigurable optical add-drop multiplexer layer of a dense wavelength division multiplexing network are disclosed. For example, the method determines the reconfigurable optical add-drop multiplexer layer has asymmetric traffic, and routes the asymmetric traffic in the reconfigurable optical add-drop multiplexer layer over a plurality of asymmetrical optical connections, wherein the plurality of asymmetrical optical connections is provided with only uni-directional equipment in the reconfigurable optical add-drop multiplexer layer.
    Type: Application
    Filed: July 31, 2016
    Publication date: November 24, 2016
    Inventors: BALAGANGADHAR G. BATHULA, Angela L. Chiu, Mark David Feuer, Rakesh Kumar Sinha, John Lester Strand, Sheryl Leigh Woodward, Weiyi Zhang
  • HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS
    Publication number: 20160331753
    Abstract: The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of formula I, their pharmaceutically acceptable salts, combinations with suitable medicament and pharmaceutical compositions thereof. The present disclosure also includes processes of preparation of the compounds and their use in methods of treatment.
    Type: Application
    Filed: July 25, 2016
    Publication date: November 17, 2016
    Applicant: LUPIN LIMITED
    Inventors: Bhavesh DAVE, Rakesh Kumar BANERJEE, Samiron PHUKAN, Abhijit Datta KHOJE, Rajkumar HANGARGE, Jitendra Sambhaji JADHAV, Venkata P. PALLE, Rajender Kumar KAMBOJ
  • Augmented reality vision system for tracking and geolocating objects of interest
    Patent number: 9495783
    Abstract: Methods and apparatuses for tracking objects comprise one or more optical sensors for capturing one or more images of a scene, wherein the one or more optical sensors capture a wide field of view and corresponding narrow field of view for the one or more images of a scene, a localization module, coupled to the one or more optical sensors for determining the location of the apparatus, and determining the location of one more objects in the one or more images based on the location of the apparatus and an augmented reality module, coupled to the localization module, for enhancing a view of the scene on a display based on the determined location of the one or more objects.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: November 15, 2016
    Assignee: SRI INTERNATIONAL
    Inventors: Supun Samarasekera, Taragay Oskiper, Rakesh Kumar, Mikhail Sizintsev, Vlad Branzoi
  • Pharmaceutical composition
    Patent number: 9492406
    Abstract: The present invention relates to a novel pharmaceutical composition having enhanced bioavailability through improved aqueous dissolution of poorly water soluble drugs, and to a method for preparing it. The invention more particularly relates to an oral pharmaceutical composition containing active ingredients of poor aqueous solubility, more specifically, antiparasitic and antipneumocystic drug Atovaquone alone or in combination with Proguanil.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: November 15, 2016
    Assignee: Ipca Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Pramilkumar Mathur, Thankachen Byju Nellithanath, Gaurav Sahal, Rakesh Kumar Bhasin, Durga Prasad Samantaray
  • Real-time system for multi-modal 3D geospatial mapping, object recognition, scene annotation and analytics
    Patent number: 9488492
    Abstract: A multi-sensor, multi-modal data collection, analysis, recognition, and visualization platform can be embodied in a navigation capable vehicle. The platform provides an automated tool that can integrate multi-modal sensor data including two-dimensional image data, three-dimensional image data, and motion, location, or orientation data, and create a visual representation of the integrated sensor data, in a live operational environment. An illustrative platform architecture incorporates modular domain-specific business analytics “plug ins” to provide real-time annotation of the visual representation with domain-specific markups.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: November 8, 2016
    Assignee: SRI INTERNATIONAL
    Inventors: Supun Samarasekera, Raia Hadsell, Rakesh Kumar, Harpreet S. Sawhney, Bogdan C. Matei, Ryan Villamil
  • IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20160317637
    Abstract: The present disclosure provides immunomodulatory compositions comprising heat-killed Caulobacter crescentus (HKCC). Immunomodulatory compositions of the present disclosure are useful for modulating an immune response in an individual. The present disclosure thus provides methods of modulating an immune response in an individual, involving administering an immunomodulatory composition comprising HKCC to the individual.
    Type: Application
    Filed: January 7, 2015
    Publication date: November 3, 2016
    Inventors: Babita Agrawal, Rakesh Kumar
  • Real-time system for multi-modal 3D geospatial mapping, object recognition, scene annotation and analytics
    Patent number: 9476730
    Abstract: A multi-sensor, multi-modal data collection, analysis, recognition, and visualization platform can be embodied in a navigation capable vehicle. The platform provides an automated tool that can integrate multi-modal sensor data including two-dimensional image data, three-dimensional image data, and motion, location, or orientation data, and create a visual representation of the integrated sensor data, in a live operational environment. An illustrative platform architecture incorporates modular domain-specific business analytics “plug ins” to provide real-time annotation of the visual representation with domain-specific markups.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: October 25, 2016
    Assignee: SRI INTERNATIONAL
    Inventors: Supun Samarasekera, Raia Hadsell, Rakesh Kumar, Harpreet S. Sawhney, Bogdan C. Matei, Ryan Villamil
  • Filter media and elements
    Patent number: 9474994
    Abstract: Fibrous filter medium that includes a melt-blown filter layer comprising melt-blown fibers and a high-efficiency glass-containing filter layer comprising glass fibers.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: October 25, 2016
    Assignee: DONALDSON COMPANY, INC.
    Inventors: Qiong Gao, Gregory S. Tronnes, Rakesh Kumar Yadav, Michael A. Madden
  • System, method and device for power amplification of a signal in an integrated circuit
    Patent number: 9450546
    Abstract: According to an aspect of present disclosure, a set of power amplifiers are used to amplify power of a signal for transmission. The signal powers from a set of power amplifiers are coupled to set of primary windings which are commonly coupled to a secondary winding such that the powers on the primary windings are additive in the secondary winding. A current path on the primary side is provided for flow of a current that is induced on at least one primary winding when a power amplifier coupled to that primary winding is in “off” state. As a result, the induced current is prevented from flowing in to the power amplifier that are in “on” state. Further, the current path isolates the power amplifiers from each other thereby enabling the power amplifiers to operate at the rated efficiency. In one embodiment, the current path is provided using a resistor network.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: September 20, 2016
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Apu Sivadas, Alok Joshi, Krishnaswamy Thiagarajan, Rakesh Kumar
  • Heterocyclyl compounds as MEK inhibitors
    Patent number: 9428499
    Abstract: The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of formula I, their pharmaceutically acceptable salts, combinations with suitable medicament and pharmaceutical compositions thereof. The present disclosure also includes processes of preparation of the compounds and their use in methods of treatment.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: August 30, 2016
    Assignee: LUPIN LIMITED
    Inventors: Bhavesh Dave, Rakesh Kumar Banerjee, Samiron Phukan, Abhijit Datta Khoje, Rajkumar Hangarge, Jitendra Sambhaji Jadhav, Venkata P. Palle, Rajender Kumar Kamboj
  • COMBINATION OF BRAF AND VEGF INHIBITORS
    Publication number: 20160243118
    Abstract: A novel combination comprising the VEGFR inhibitor 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, with a B-Raf inhibitor, particularly N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of VEGFR and/or B-Raf is beneficial.
    Type: Application
    Filed: May 3, 2016
    Publication date: August 25, 2016
    Inventor: RAKESH KUMAR
  • ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER
    Publication number: 20160235714
    Abstract: A novel combination comprising an androgen receptor inhibitor, for example: 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide or a pharmaceutically acceptable salt thereof, and an AKT inhibiting compound, for example: N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, and optional additional antineoplastic agents; pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which androgen receptor inhibition and/or AKT inhibition is beneficial, e.g., cancer.
    Type: Application
    Filed: October 1, 2014
    Publication date: August 18, 2016
    Inventors: Rakesh KUMAR, Shannon Renae MORRIS, Mark J. CORNFELD
  • Extracting document data from multiple sources for display on a mobile communication device using HTTP request headers having XML strings therein
    Patent number: 9418169
    Abstract: A method operable on a mobile communication device, comprising opening a browser session and issuing an HTTP request for document data, wherein the request includes an XML descriptor added to headers of the HTTP request for identifying the request and the document data being requested, and receiving an HTTP response including the XML descriptor along with document binary data representing respective chunks of the document data for display on the mobile communication device.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: August 16, 2016
    Assignee: BlackBerry Limited
    Inventors: Dan Mihai Dumitru, Rakesh Kumar Arora, Randy Michael Rossi
  • COMBINATION
    Publication number: 20160228456
    Abstract: A novel combination comprising a 17 ?-hydroxylase/C17,20 lyase inhibitor, for example: (3?)-17-(pyridin-3-yl)androsta-5, 16-dien-3-ol or a pharmaceutically acceptable salt or ester thereof, and an AKT inhibitor, for example: N-{(1 S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, and optional additional antineoplastic agents; pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of 17 ?-hydroxylase/C17,20 lyase and/or AKT inhibition is beneficial, e.g., cancer.
    Type: Application
    Filed: October 1, 2014
    Publication date: August 11, 2016
    Inventors: Mark J. CORNFELD, Rakesh KUMAR, Shannon Renae MORRIS
  • Method and apparatus for routing traffic using asymmetrical optical connections
    Patent number: 9413640
    Abstract: A method, computer-readable storage device and apparatus for routing traffic in a reconfigurable optical add-drop multiplexer layer of a dense wavelength division multiplexing network are disclosed. For example, the method determines the reconfigurable optical add-drop multiplexer layer has asymmetric traffic, and routes the asymmetric traffic in the reconfigurable optical add-drop multiplexer layer over a plurality of asymmetrical optical connections, wherein the plurality of asymmetrical optical connections is provided with only uni-directional equipment in the reconfigurable optical add-drop multiplexer layer.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: August 9, 2016
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Balagangadhar G. Bathula, Angela L. Chiu, Mark David Feuer, Rakesh Kumar Sinha, John Lester Strand, Sheryl Leigh Woodward, Weiyi Zhang
  • Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer
    Patent number: 9402846
    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: August 2, 2016
    Assignee: Novartis AG
    Inventors: Melissa Dumble, Tona Gilmer, Rakesh Kumar, Sylvie Laquerre, Peter F. Lebowitz, Shannon Renae Morris